نتایج جستجو برای: montanide

تعداد نتایج: 327  

2017
Meta Roestenberg Ed Remarque Erik de Jonge Rob Hermsen Hildur Blythman Odile Leroy Egeruan Imoukhuede Soren Jepsen Opokua Ofori-Anyinam Bart Faber Clemens H. M. Kocken Miranda Arnold Vanessa Walraven Karina Teelen Will Roeffen Quirijn de Mast W. Ripley Ballou Joe Cohen Marie Claude Dubois Stephane Ascarateil Andre van der Ven Alan Thomas Robert Sauerwein

Background: Plasmodium falciparum Apical Membrane Antigen 1 (PfAMAI) is a candidate vaccine antigen expressed by merozoites and sporozoites. It plays a key role in red blood cell and hepatocyte invasion that can be blocked by antibodies. Methodology/Principal Findings: We assessed the safety and immunogenicity of recombinant PfAMAI in a doseescalating, phase la trial. PfAMAI FVO strain, produce...

2015
Stephane Ascarateil Aude Puget Jerome Gaucheron Marie-Eve Koziol

Introduction MontanideTM ISA 51 VG and MontanideTM ISA 720 VG are adjuvants dedicated to human therapeutic vaccines. The adjuvants are rendering stable water-in-oil (W/O) emulsions when mixed with water phase. In these formulations the active ingredients are entrapped in droplets of water surrounded by continuous oil phase. It allows a protection against degradation and slow release of the acti...

Journal: :PLoS ONE 2008
Jinhong Hu Zhihui Chen Jun Gu Mobin Wan Qian Shen Marie-Paule Kieny Jia He Zhen Li Qingfeng Zhang Zarifah Hussain Reed Yongmei Zhu Wenjie Li Yang Cao Li Qu Zhifang Cao Qiang Wang Haitao Liu Xuegong Pan Xiudong Huang Dongmei Zhang Xiangyang Xue Weiqing Pan

BACKGROUND The P. falciparum chimeric protein 2.9 (PfCP-2.9) consisting of the sequences of MSP1-19 and AMA-1 (III) is a malaria vaccine candidate that was found to induce inhibitory antibodies in rabbits and monkeys. This was a phase I randomized, single-blind, placebo-controlled, dose-escalation study to evaluate the safety and immunogenicity of the PfCP-2.9 formulated with a novel adjuvant M...

2013
Trine Zeeberg Iversen Lotte Engell-Noerregaard Eva Ellebaek Rikke Andersen Stine Kiaer Larsen Jon Bjoern Claus Zeyher Birthe Moerk Thomsen Bente Holm Per thor Straten Inge Marie Svane

Purpose: To investigate targeting of indoleamine 2,3 dioxygenase (IDO) enzyme using a synthetic peptide vaccine administered to patients with metastatic non–small cell lung cancer (NSCLC). Experimental Design: In a clinical phase I study, we treated 15HLA-A2–positive patients with stage III– IV NSCLC in disease stabilization after standard chemotherapy. Patients were treated with imiquimod oint...

2014
Ratna B. Gurung Auriol C. Purdie Richard J. Whittington Douglas J. Begg

Control of Johne's disease, caused by Mycobacterium avium subspecies paratuberculosis (MAP) in ruminants using commercially available vaccine reduces production losses, mortality, fecal shedding and histopathological lesions but does not provide complete protection from infection and interferes with serological diagnosis of Johne's disease and bovine tuberculosis. At this time no recombinant an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید